Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2384-2021Class II

MY01 Continuous Compartmental Pressure Monitor, Reference Number MY01-0001

MY01, Inc. / initiated 2021-06-28 / Terminated / root cause: manufacturing process

MY01, INC. began a recall of MY01 Continuous Compartmental Pressure Monitor, Reference Number MY01-0001 on . FDA classified it as Class II and gives the reason as "There is an incorrect version of the needle in the introducer part of devices. The affected Lots were manufactured using needles with a needle trocar geometry which is out of specification and may require a slightly...". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-2384-2021
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
MY01, Inc.
Product
MY01 Continuous Compartmental Pressure Monitor, Reference Number MY01-0001
Product code
LXC Monitor, Pressure, Intracompartmental
Reason for recall
There is an incorrect version of the needle in the introducer part of devices. The affected Lots were manufactured using needles with a needle trocar geometry which is out of specification and may require a slightly higher push force from the user to penetrate the patient skin.
Root cause tag
manufacturing process
FDA root cause
Under Investigation by firm
Action
A Medical Device Advisory Notice dated 6/28/21 was sent to customers. Clinicians Responsibilities/ Actions required: 1. Review this notification for awareness of the contents 2. Identify and quarantine any unused affected products in your inventory for return to MY01 Inc. Contact Customer Success team by phone (+1 (855) 292-6901) or email ([email protected]) to arrange for your replacements. 3. There are no specific patient monitoring instructions related to this voluntary product removal that are recommended beyond your existing follow up schedule. 4. Complete Attachment 1- Certificate of acknowledgement and email to [email protected] by 07-Jul-2021. 5. Include a copy of Attachment 1- Certificate of acknowledgement with product to be returned. Please use the return shipping label (to be provided by MY01 Inc.), please return affected product to: Regulatory Affairs and Quality Management MY01 Inc. 400 Maisonneuve Boulevard West, Suite 700, Montreal, Quebec, Canada H3A 1L4 6. Retain a copy of this document and Attachment 1- Certificate of acknowledgement with your records. 7. If you have further questions or concerns after reviewing this notice, please call the customer service team at 1-855-292-6901. Alternatively, your questions may be emailed to: [email protected] Under 21 CFR 803, manufacturers are also required to report any serious injuries where a product has contributed or may have contributed to the event. Please keep MY01 Inc. informed of any adverse events associated with this by emailing [email protected] or call +1(855)-292-6901.
Quantity in commerce
37 units
Distribution
US Nationwide distribution in the states of MD, OH, CA, NY.
Product codes and lots
Lot Numbers: 9448532 9448838 9448979 9449000 9449237

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2384-2021
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2384-2021Class IITerminatedVoluntary: Firm initiated